Article
Effects of netarsudil-family Rho kinase inhibitors on human trabecular meshwork cell…
medRxiv · 2022 · Bague, T.; Singh, A.; Ghosh, R.; Yoo, H.; Kelly, C.; deLong, M. A.; Kopczynski, C. C.; Herberg, S.
Key facts
| Title | Effects of netarsudil-family Rho kinase inhibitors on human trabecular meshwork cell contractility and actin remodeling using a bioengineered ECM hydrogel |
|---|---|
| First author | Bague, T.; Singh, A.; Ghosh, R.; Yoo, H.; Kelly, C.; deLong, M. A.; Kopczynski, C. C.; Herberg, S. |
| Journal | medRxiv |
| Published | May 19, 2022 |
| DOI | 10.1101/2022.05.19.492652 |
| Devices mentioned | K802418 |
| Product codes mentioned | KIS |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1